MedTrace Logo

PRP vs Corticosteroid in Baker's Cyst

NCT02249377 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-03-18

Study results available
· View outcomes & findings →

Summary

This is a Prospective study with Randomized patients into either Ultrasound-guided Platelets-Rich-Plasma injection and Ultrasound guided Corticosteroid Injection, with 3 months and 6 months follow ups after aspiration at our institution. There will be 25 patients in each group, including any patient with symptomatic baker's cyst.

Conditions

  • Baker's Cyst

Interventions

OTHER

Platelets-Rich-Plasma

Platelet-Rich Plasma

DRUG

Corticosteroid

Corticosteroid

Sponsors & Collaborators

Principal Investigators

  • Eric J Strauss, MD · NYU Langone Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-04-01
Completion
2017-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02249377 on ClinicalTrials.gov